Skip to content

Melanotan I (afamelanotide) studies: 218 papers with results

Page 4 of 5

  1. Desensitization of melanotropin receptors in COS-7 cells.

    Polgar WE · Life sciences · 1996

    In vitro (cells) · 4 results

  2. Melanocortin-receptor 4 activation modulates proliferation and differentiation of rat postnatal hippocampal neural precursor cells.

    Carniglia L · Neuropharmacology · 2024

    In vitro (cells) · wistar rat · 8 results

  3. Hormonal regulation of the mouse adrenal melanocortinergic system.

    Soltani Y · Journal of endocrinological investigation · 2009

    In vitro (cells) · mouse · 1 result

  4. A Dominant Mutation in Gαs-Protein Increases Hair Pigmentation.

    Goff PS · Pigment cell & melanoma research · 2025

    In vitro (cells) · mouse · 2 results

  5. Pharmacological function of melanocortin-3 receptor in goldfish (Carassius auratus).

    Yao MX · General and comparative endocrinology · 2025

    In vitro (cells) · goldfish · 3 results

  6. Regulation of Melanocortin-5 Receptor Pharmacology by Two Isoforms of MRAP2 in Ricefield Eel (Monopterus albus)

    Liu T · Journal of the Endocrine Society · 2021

    In vitro (cells) · monopterus albus · 2 results

  7. Change in gene expression profile induced by alpha-melanocyte stimulating hormone in a malignant mesothelioma cell line.

    Colombo G · Cellular and molecular biology (Noisy-le-Grand, France) · 2006

    In vitro (cells) · 5 results

  8. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.

    Kopanchuk S · European journal of pharmacology · 2005

    In vitro (cell-free) · 2 results

  9. Peptide-lipid interaction monitored by spin labeled biologically active melanocortin peptides.

    Fernandez RM · Peptides · 2005

    In vitro (cell-free) · 4 results

  10. Computational Screening of Approved Drugs for Inhibition of the Antibiotic Resistance Gene mecA in Methicillin-Resistant Staphylococcus aureus (MRSA) Strains.

    Otarigho B · Biotech (Basel (Switzerland)) · 2023

    In silico · 1 result

  11. An improved imaging agent for malignant melanoma, based on [Nle4,D-Phe7]alpha-melanocyte stimulating hormone.

    Bard DR · Nuclear medicine communications · 1995

    Not a test of Melanotan I (afamelanotide) alone · 8 results

  12. Molecular mechanism of the intracellular segments of the melanocortin-4 receptor for NDP-MSH signaling.

    Yang Y · Biochemistry · 2005

    Not a test of Melanotan I (afamelanotide) alone · 7 results

  13. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.

    Frändberg PA · Biochemical and biophysical research communications · 2001

    Not a test of Melanotan I (afamelanotide) alone · 6 results

  14. Intercepting the complement amplification loop through podocyte MC5R signaling ameliorates membranous nephropathy.

    Liu J · Molecular therapy : the journal of the American Society of Gene Therapy · 2025

    Not a test of Melanotan I (afamelanotide) alone · 8 results

  15. Preclinical evaluation of MC1R targeted radiopharmaceuticals using the 203/212Pb theranostic pair.

    Scaffidi-Muta JM · European journal of medicinal chemistry · 2026

    Not a test of Melanotan I (afamelanotide) alone · 6 results

  16. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.

    Froidevaux S · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2002

    Not a test of Melanotan I (afamelanotide) alone · 5 results

  17. A (99m)Tc(CO)(3)-labeled pyrazolyl-alpha-melanocyte-stimulating hormone analog conjugate for melanoma targeting.

    Raposinho PD · Nuclear medicine and biology · 2008

    Not a test of Melanotan I (afamelanotide) alone · 5 results

  18. Downregulation of melanocortin receptors in brain areas involved in food intake and reward mechanisms in obese (OLETF) rats.

    Lindblom J · Brain research · 2000

    Not a test of Melanotan I (afamelanotide) alone · 5 results

  19. Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres.

    Lu W · Clinical cancer research : an official journal of the American Association for Cancer Research · 2009

    Not a test of Melanotan I (afamelanotide) alone · 4 results

  20. Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding.

    Harrold JA · Diabetes · 1999

    Not a test of Melanotan I (afamelanotide) alone · 4 results

  21. Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions.

    Handl HL · Analytical biochemistry · 2004

    Not a test of Melanotan I (afamelanotide) alone · 4 results

  22. Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R).

    Handl HL · Bioconjugate chemistry · 2007

    Not a test of Melanotan I (afamelanotide) alone · 4 results

  23. In vivo evaluation of 99mTc/188Re-labeled linear alpha-melanocyte stimulating hormone analogs for specific melanoma targeting.

    Chen J · Nuclear medicine and biology · 1999

    Not a test of Melanotan I (afamelanotide) alone · 4 results

  24. Interactions of the melanocortin-4 receptor with the peptide agonist NDP-MSH.

    Chapman KL · Journal of molecular biology · 2010

    Not a test of Melanotan I (afamelanotide) alone · 4 results

  25. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.

    Fleck BA · Biochemistry · 2007

    Not a test of Melanotan I (afamelanotide) alone · 4 results

  26. Structural insight into the MC4R conformational changes via different agonist-mediated receptor signaling.

    Yang Y · Biochemistry · 2014

    Not a test of Melanotan I (afamelanotide) alone · 4 results

  27. Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study.

    Shetty N · Photochemistry and photobiology · 2026

    Not a test of Melanotan I (afamelanotide) alone · 4 results

  28. Molecular determinants of ligand binding to the human melanocortin-4 receptor.

    Yang YK · Biochemistry · 2000

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  29. Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407.

    Bhardwaj R · Journal of pharmaceutical sciences · 1996

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  30. Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands.

    van der Kraan M · Endocrinology · 1998

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  31. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors.

    Haskell-Luevano C · Journal of medicinal chemistry · 2001

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  32. The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.

    Grimes PE · JAMA dermatology · 2013

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  33. Truncation studies of alpha-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity.

    Haskell-Luevano C · Peptides · 1996

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  34. Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction.

    Chen M · Biochemistry · 2006

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  35. Fluorescence anisotropy assay for pharmacological characterization of ligand binding dynamics to melanocortin 4 receptors.

    Veiksina S · Analytical biochemistry · 2010

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  36. Squalene-derived flexible linkers for bioactive peptides.

    Jagadish B · Bioorganic & medicinal chemistry letters · 2007

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  37. Fluorescence study of conformational properties of melanotropins labeled with aminobenzoic acid.

    Ito AS · Biophysical journal · 2001

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  38. Acid-base titration of melanocortin peptides: evidence of Trp rotational conformers interconversion.

    Fernandez RM · Biopolymers · 2005

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  39. Silica-Assisted Solid-Phase Peptide Synthesis (SiPPS).

    Nkwanyana N · Journal of peptide science : an official publication of the European Peptide Society · 2025

    Not a test of Melanotan I (afamelanotide) alone · 6 results

  40. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue].

    Ying Y · Yao xue xue bao = Acta pharmaceutica Sinica · 2007

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  41. Polysorbate 80 coated chitosan nanoparticles for delivery of α-melanocyte stimulating hormone analog (NDP-MSH) to the brain reverse cognitive impairment related to neuroinflammation produced by a high-fat diet (HFD).

    Herrera G · Neuropharmacology · 2024

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  42. Investigation of the stability profile of therapeutic α-MSH analogue: Insights from liquid chromatography-high resolution mass spectrometry analysis of afamelanotide.

    Chawathe A · Journal of pharmaceutical and biomedical analysis · 2026

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  43. Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists.

    Pogozheva ID · Biochemistry · 2005

    Not a test of Melanotan I (afamelanotide) alone · 2 results

  44. Structural insights into ligand recognition and activation of the melanocortin-4 receptor.

    Zhang H · Cell research · 2021

    Not a test of Melanotan I (afamelanotide) alone · 3 results

  45. Expression of melanocortin receptors and pro-opiomelanocortin in the rat spinal cord in relation to neurotrophic effects of melanocortins.

    van der Kraan M · Brain research. Molecular brain research · 1999

    Not a test of Melanotan I (afamelanotide) alone · 2 results

  46. A tumor-targeted immune checkpoint blocker.

    Zhang Y · Proceedings of the National Academy of Sciences of the United States of America · 2019

    Not a test of Melanotan I (afamelanotide) alone · 2 results

  47. Rigid linkers for bioactive peptides.

    Vagner J · Bioconjugate chemistry · 2006

    Not a test of Melanotan I (afamelanotide) alone · 2 results

  48. Identification of ligand binding residues in extracellular loops of the melanocortin 1 receptor.

    Chhajlani V · Biochemical and biophysical research communications · 1996

    Not a test of Melanotan I (afamelanotide) alone · 2 results

  49. A novel non-synonymous mutation in the melanocortin-4 receptor gene (MC4R) in a 2-year-old Austrian girl with extreme obesity.

    Rettenbacher E · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2007

    Not a test of Melanotan I (afamelanotide) alone · 2 results

  50. Design, synthesis, and validation of a branched flexible linker for bioactive peptides.

    Bowen ME · The Journal of organic chemistry · 2007

    Not a test of Melanotan I (afamelanotide) alone · 2 results

How PepBank reports evidence